107 related articles for article (PubMed ID: 19502814)
1. Tryptophan metabolites: a scent signature for cancer's immunosuppressive status?
Zhang W
Cancer Biol Ther; 2009 Jul; 8(14):1409-10. PubMed ID: 19502814
[No Abstract] [Full Text] [Related]
2. IDO inhibits T-cell function through suppressing Vav1 expression and activation.
Li R; Wei F; Yu J; Li H; Ren X; Hao X
Cancer Biol Ther; 2009 Jul; 8(14):1402-8. PubMed ID: 19597340
[TBL] [Abstract][Full Text] [Related]
3. Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan.
van Baren N; Van den Eynde BJ
Cancer Immunol Res; 2015 Sep; 3(9):978-85. PubMed ID: 26269528
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer.
Barreto FS; Chaves Filho AJM; de Araújo MCCR; de Moraes MO; de Moraes MEA; Maes M; de Lucena DF; Macedo DS
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):165-180. PubMed ID: 29543650
[TBL] [Abstract][Full Text] [Related]
5. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
6. The tryptophan derivative, tranilast, and conditioned medium with indoleamine 2,3-dioxygenase-expressing cells inhibit the proliferation of lymphoid malignancies.
Suwa S; Kasubata A; Kato M; Iida M; Watanabe K; Miura O; Fukuda T
Int J Oncol; 2015 Mar; 46(3):1369-76. PubMed ID: 25572287
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.
Biragyn A; Longo DL
Semin Cancer Biol; 2012 Feb; 22(1):50-9. PubMed ID: 22257681
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of indoleamine 2,3-dioxygenase by stereoisomers of 1-methyl tryptophan in an experimental graft-versus-tumor model.
Lim JY; Lee SE; Park G; Choi EY; Min CK
Exp Hematol; 2014 Oct; 42(10):862-6.e3. PubMed ID: 24971697
[TBL] [Abstract][Full Text] [Related]
9. [Immune modulation by tryptophan metabolism: relevance for autoimmune and tumor diseases].
Platten M; Wick W; Opitz C
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1478-82. PubMed ID: 23821452
[No Abstract] [Full Text] [Related]
10. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
11. Intestine-Specific Homeobox Gene
Wang LT; Chiou SS; Chai CY; Hsi E; Yokoyama KK; Wang SN; Huang SK; Hsu SH
Cancer Res; 2017 Aug; 77(15):4065-4077. PubMed ID: 28625979
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism.
Takikawa O
Biochem Biophys Res Commun; 2005 Dec; 338(1):12-9. PubMed ID: 16176799
[TBL] [Abstract][Full Text] [Related]
13. [Indoleamine 2,3-dioxygenase in oncology and psychiatry].
Vonka V; Horáček J
Cas Lek Cesk; 2015; 154(1):3-10. PubMed ID: 25994821
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.
Taher YA; Piavaux BJ; Gras R; van Esch BC; Hofman GA; Bloksma N; Henricks PA; van Oosterhout AJ
J Allergy Clin Immunol; 2008 Apr; 121(4):983-91.e2. PubMed ID: 18179817
[TBL] [Abstract][Full Text] [Related]
15. Targeting tryptophan availability to tumors: the answer to immune escape?
Badawy AA
Immunol Cell Biol; 2018 Nov; 96(10):1026-1034. PubMed ID: 29888434
[TBL] [Abstract][Full Text] [Related]
16. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
Gostner JM; Becker K; Überall F; Fuchs D
Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107
[TBL] [Abstract][Full Text] [Related]
17. [A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].
Van den Eynde B
Bull Mem Acad R Med Belg; 2003; 158(7-9):356-63; discussion 364-5. PubMed ID: 15132006
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
19. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model.
Jiang X; Xu L; Tang L; Liu F; Chen Z; Zhang J; Chen L; Pang C; Yu X
J Neuroinflammation; 2018 Jan; 15(1):3. PubMed ID: 29301550
[TBL] [Abstract][Full Text] [Related]
20. Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS/MS in plasma and tumor.
Wang W; Zhuang X; Liu W; Dong L; Sun H; Du G; Ye L
Bioanalysis; 2018 Aug; 10(16):1335-1344. PubMed ID: 30130131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
